Centessa Pharmaceuticals Limited (CNTA) Social Stream
CENTESSA PHARMACEUTICALS PLC (CNTA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CNTA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 2 | $37 | $37 | $37 | $6.73 | 449.78% |
| 2022-03-30 | 2 | $37 | $20 | $28.5 | $6.73 | 323.48% |
| 2022-04-05 | 3 | $37 | $19 | $28 | $6.73 | 316.05% |
| 2022-05-16 | 3 | $37 | $12 | $22.666 | $6.73 | 236.79% |
| 2022-05-24 | 3 | $37 | $8 | $20 | $6.73 | 197.18% |
| 2022-06-02 | 4 | $15 | $4 | $9 | $6.73 | 33.73% |
| 2022-06-17 | 4 | $19 | $4 | $11.5 | $6.73 | 70.88% |
| 2022-07-15 | 4 | $19 | $4 | $10.25 | $6.73 | 52.3% |
| 2022-08-11 | 4 | $11 | $4 | $7.25 | $6.73 | 7.73% |
| 2022-10-12 | 4 | $11 | $4 | $6 | $6.73 | -10.85% |
| 2022-11-14 | 4 | $11 | $4 | $6 | $6.73 | -10.85% |
| 2023-01-24 | 5 | $11 | $4 | $5.75 | $6.73 | -14.56% |
| 2023-05-16 | 6 | $11 | $4 | $5.8 | $6.73 | -13.82% |
| 2023-06-12 | 7 | $11 | $4 | $6.416 | $6.73 | -4.67% |
| 2023-08-14 | 7 | $15 | $4 | $7.083 | $6.73 | 5.25% |
| 2023-08-15 | 7 | $15 | $4 | $8.166 | $6.73 | 21.34% |
| 2023-11-13 | 7 | $15 | $5 | $9.8 | $6.73 | 45.62% |
| 2023-11-15 | 7 | $15 | $5 | $10 | $6.73 | 48.59% |
The Trend in the Analyst Price Target
CNTA's average price target has moved up $4 over the prior 12 months.
Over the past 42 weeks, CNTA's average upside potential has been 33.88%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-12 | 5 | 11 | 4 | 5.800 | 4.65 | 24.73% |
| 2023-05-16 | 5 | 11 | 4 | 5.800 | 4.47 | 29.75% |
| 2023-06-12 | 7 | 11 | 4 | 6.416 | 4.64 | 38.28% |
| 2023-07-25 | 7 | 15 | 4 | 7.083 | 7.14 | -0.8% |
| 2023-11-13 | 7 | 15 | 5 | 9.800 | 6.24 | 57.05% |
CNTA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.57 | 5 | 0 | 2 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 26 weeks, CNTA's average broker recommendation rating improved by 0.83.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CNTA as an investment opportunity.
- In terms of how CENTESSA PHARMACEUTICALS PLC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1964.21% of that group.
- To contextualize these metrics, consider that out of all US stocks, CENTESSA PHARMACEUTICALS PLC's average analyst price target is higher than 357.78% of them.
- In the context of all US stocks, CENTESSA PHARMACEUTICALS PLC's number of analysts covering the stock is higher than 429.07% of them.
- CNTA has a higher upside potential (average analyst target price relative to current price) than 899.76% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CENTESSA PHARMACEUTICALS PLC are ALZN, CYT, and GHRS.
View All Top Stocks by Price Target
What is the outlook for CNTA? Use POWR Ratings for clearer insight into price direction.